764 Expansion with IL-15 increases cytotoxicity of Vγ9Vδ2 T cells and is associated with higher levels of cytotoxic molecules and T-bet

764 Expansion with IL-15 increases cytotoxicity of Vγ9Vδ2 T cells and is associated with higher levels of cytotoxic molecules and T-bet

Bibliographic Details
Main Authors:	Per thor Straten, Pia Aehnlich, Ana Micaela Carnaz Simoes, Signe Skadborg, Gitte Olofsson
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet
by: Pia Aehnlich, et al.
Published: (2020-08-01)

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
by: Gitte Holmen Olofsson, et al.
Published: (2021-06-01)

Cytotoxicity of Vγ9Vδ2 T cells towards Colon Cancer Cells
by: Grero, Dhanya
Published: (2014)

Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity.
by: Matilde Todaro, et al.
Published: (2013-01-01)

Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
by: Focaccetti Chiara, et al.
Published: (2009-09-01)

Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
by: Agnete Witness Praest Jensen, et al.
Published: (2021-01-01)

B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells
by: Huimin Lu, et al.
Published: (2020-01-01)

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells
by: Daisuke Okuno, et al.
Published: (2020-07-01)

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells
by: Carla E. Cano, et al.
Published: (2021-07-01)

TGF-β enhances the cytotoxic activity of Vδ2 T cells
by: Christian Peters, et al.
Published: (2019-01-01)

Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells
by: Alessandra Sacchi, et al.
Published: (2018-06-01)

Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model
by: Teruki Shimizu, et al.
Published: (2018-05-01)

Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
by: Zhan Wang, et al.
Published: (2018-06-01)

Evolution of Vγ9Vδ2 T-cells
by: Karunakaran, Mohindar Murugesh
Published: (2014)

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
by: Manja Idorn, et al.
Published: (2018-08-01)

New <i>γ</i>-Halo-<i>δ</i>-lactones and <i>δ</i>-Hydroxy-<i>γ</i>-lactones with Strong Cytotoxic Activity
by: Angelika Kamizela, et al.
Published: (2019-05-01)

Vδ2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated Cytotoxicity
by: Eleonora Cimini, et al.
Published: (2019-09-01)

Sensing of pyrophosphate metabolites by Vγ9Vδ2 T cells.
by: Erin J Adams, et al.
Published: (2015-01-01)

Adoptive cancer immunotherapy with human Vγ2vδ2 T cells
by: Nada, Mohanad Hameed
Published: (2016)

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
by: Timm Hoeres, et al.
Published: (2018-04-01)

Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire
by: Carrie R. Willcox, et al.
Published: (2018-07-01)

Oral Allergic Syndrome and Recombinant Allergens rBet v 1 and rBet v 2
by: S. Cadoni, et al.
Published: (2007-01-01)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
by: Mijeong Lee, et al.
Published: (2019-03-01)

Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.
by: Shou-Hui Du, et al.
Published: (2016-01-01)

The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
by: Martin S. Davey, et al.
Published: (2018-05-01)

BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.
by: Anastasia Wyce, et al.
Published: (2013-01-01)

836 Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
by: Angus Dalgleish, et al.
Published: (2020-11-01)

An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
by: Thomas Herrmann, et al.
Published: (2020-06-01)

Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis
by: Gerstein M, et al.
Published: (2008-09-01)

Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescenceResearch in context
by: Weili Xu, et al.
Published: (2019-01-01)

Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates.
by: Crystal Y Chen, et al.
Published: (2013-08-01)

Pindar, <i>Nemean</i> 7.64-67
by: Glen W. Most
Published: (2004-09-01)

Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients
by: Liping Yan, et al.
Published: (2018-09-01)

BTN3A1 in the immune response of Vγ9Vδ2 T cells
by: Riaño, Rubén Felipe
Published: (2016)

Thymic development and peripheral functional polarisation of human Vγ9Vδ2 T cells
by: Papadopoulou, Maria
Published: (2020)

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
by: Zsolt Sebestyen, et al.
Published: (2016-05-01)

Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells
by: Ling Ma, et al.
Published: (2020-06-01)

Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance
by: Oliver Nussbaumer, et al.
Published: (2020-03-01)

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection
by: Jennifer Howard, et al.
Published: (2018-11-01)

Epidemiology of Deltacoronaviruses (δ-CoV) and Gammacoronaviruses (γ-CoV) in Wild Birds in the United States
by: Francine C. Paim, et al.
Published: (2019-09-01)

Cannot write session to /tmp/vufind_sessions/sess_3pf3v6png613ih97ie3rq8ed2n